Yi Liu
Gründer bei Kumquat Biosciences, Inc.
Profil
Yi Liu was the founder of Kura Oncology, Inc. (2014), Intellikine LLC (2007), and Kumquat Biosciences, Inc. (2018) where he held the titles of Chief Scientific Officer, Vice President-Drug Discovery, and Chief Executive Officer & Director respectively.
He held former positions as Principal at CuraGen Corp., SGX Pharmaceuticals, Inc., and Novartis Institute for Functional Genomics, Inc. and as Chief Scientific Officer at Zeta Acquisition Corp.
III.
He was also the Chief Scientific Officer at Wellspring Biosciences LLC from 2012 to 2014.
Dr. Liu earned a doctorate degree from Princeton University, an undergraduate degree from Tsinghua University, and a graduate degree from Beijing University of Technology.
Aktive Positionen von Yi Liu
| Unternehmen | Position | Beginn |
|---|---|---|
Kumquat Biosciences, Inc.
 Kumquat Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Kumquat Biosciences, Inc. provides biotechnology services. The company was founded by Yi Liu and Pingda Ren and is headquartered in San Diego, CA. | Gründer | 01.11.2018 |
Ehemalige bekannte Positionen von Yi Liu
| Unternehmen | Position | Ende |
|---|---|---|
Wellspring Biosciences LLC
 Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Wellspring Biosciences LLC discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases. The private company is based in La Jolla, CA. The company was founded by Pingda Ren. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2014 |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Gründer | 01.05.2012 |
Zeta Acquisition Corp. III
 Zeta Acquisition Corp. III MiscellaneousMiscellaneous Zeta Acquisition Corp. III operates as a blank check company. It was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. The firm will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. The company was founded on November 16, 2007 and is headquartered in Des Moines, IA. | Technik-/Wissenschafts-/F&E-Leiter | - |
| KURA ONCOLOGY, INC. | Gründer | - |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - |
Ausbildung von Yi Liu
| Princeton University | Doctorate Degree |
| Tsinghua University | Undergraduate Degree |
| Beijing University of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KURA ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Zeta Acquisition Corp. III
Zeta Acquisition Corp. III MiscellaneousMiscellaneous Zeta Acquisition Corp. III operates as a blank check company. It was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. The firm will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. The company was founded on November 16, 2007 and is headquartered in Des Moines, IA. | Miscellaneous |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Health Technology |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Commercial Services |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Health Technology |
Wellspring Biosciences LLC
Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Wellspring Biosciences LLC discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases. The private company is based in La Jolla, CA. The company was founded by Pingda Ren. | Health Technology |
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Kumquat Biosciences, Inc. provides biotechnology services. The company was founded by Yi Liu and Pingda Ren and is headquartered in San Diego, CA. | Commercial Services |
